Kistler-Tiffany Companies’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8
Closed -$2K 784
2022
Q2
$2K Hold
8
﹤0.01% 706
2022
Q1
$4K Hold
8
﹤0.01% 672
2021
Q4
$5K Hold
8
﹤0.01% 645
2021
Q3
$6K Hold
8
﹤0.01% 631
2021
Q2
$10K Hold
8
﹤0.01% 559
2021
Q1
$8K Hold
8
﹤0.01% 541
2020
Q4
$11K Hold
8
﹤0.01% 489
2020
Q3
$5K Hold
8
﹤0.01% 538
2020
Q2
$5K Buy
+8
New +$4.62K ﹤0.01% 503

Other funds holding CDLX

Kistler-Tiffany Companies's CDLX Position: Q3 2022 in Review

Kistler-Tiffany Companies sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 8 shares — an estimated $2K sold.

Kistler-Tiffany Companies first reported a position in CDLX in Q2 2020 and held it in 9 quarters. The position peaked at $11K in Q4 2020. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Kistler-Tiffany Companies reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 8 Cardlytics shares in Q3 2022, an estimated $2K.
  • Kistler-Tiffany Companies first reported a position in Cardlytics in Q2 2020 and held it in 9 quarters.
  • Kistler-Tiffany Companies's Cardlytics position peaked at $11K in Q4 2020.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Kistler-Tiffany Companies's 13F filing for Q3 2022, filed 9 Nov 2022.